Birdwatch Note
2024-02-16 11:45:50 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ワクチンが癌のリスクになる事を示すデータは米国立がん研究所にすら把握されていません↓ https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer# また悪性リンパ腫は高齢化に伴い、毎年400名程度ずつコロナ前から死亡が増加しており↓22年も特段の異常は見られません。 15:11868 16:12384 17:12473 18:12830 19:13049 20:13786 21:13781 22:14230 21年までの出典 https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#a7 22年の出典 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000040067362&fileKind=1 重症予防効果はオミクロン期も観察研究のメタ解析で示されており↓ https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00015-2/fulltext 21年後半～22年3月の期間の超過死亡も高接種地域程小さかった事が報告されています↓ https://jamanetwork.com/journals/jama/article-abstract/2798990
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1758426175901413851
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1758457655620968803
- noteId - 1758457655620968803
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1708083950320
- tweetId - 1758426175901413851
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ワクチンが癌のリスクになる事を示すデータは米国立がん研究所にすら把握されていません↓ https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer# また悪性リンパ腫は高齢化に伴い、毎年400名程度ずつコロナ前から死亡が増加しており↓22年も特段の異常は見られません。 15:11868 16:12384 17:12473 18:12830 19:13049 20:13786 21:13781 22:14230 21年までの出典 https://ganjoho.jp/reg_stat/statistics/data/dl/index.html#a7 22年の出典 https://www.e-stat.go.jp/stat-search/file-download?statInfId=000040067362&fileKind=1 重症予防効果はオミクロン期も観察研究のメタ解析で示されており↓ https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00015-2/fulltext 21年後半～22年3月の期間の超過死亡も高接種地域程小さかった事が報告されています↓ https://jamanetwork.com/journals/jama/article-abstract/2798990
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-02-16 11:45:50 UTC (1708083950320) |
2024-02-16 18:28:53 UTC (1708108133788) |
CURRENTLY_RATED_HELPFUL | 2024-02-17 01:35:32 UTC (1708133732802) |
CURRENTLY_RATED_HELPFUL | 2024-02-16 18:28:53 UTC (1708108133788) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-02-16 16:59:02 -0600 | Rating Details | |
| 2024-02-16 16:52:14 -0600 | Rating Details | |
| 2024-02-16 15:29:27 -0600 | Rating Details | |
| 2024-02-16 14:03:04 -0600 | Rating Details | |
| 2024-02-16 10:25:36 -0600 | Rating Details | |
| 2024-02-16 09:03:41 -0600 | Rating Details | |
| 2024-02-16 08:12:45 -0600 | Rating Details | |
| 2024-02-16 08:08:04 -0600 | Rating Details | |
| 2024-02-16 07:49:49 -0600 | Rating Details | |
| 2024-02-16 07:01:39 -0600 | Rating Details | |
| 2024-02-16 06:57:14 -0600 | Rating Details | |
| 2024-02-16 06:45:45 -0600 | Rating Details | |
| 2024-02-16 06:44:35 -0600 | Rating Details | |
| 2024-02-16 06:40:19 -0600 | Rating Details | |
| 2024-02-16 06:29:57 -0600 | Rating Details | |
| 2024-02-16 06:26:21 -0600 | Rating Details | |
| 2024-02-16 06:25:58 -0600 | Rating Details | |
| 2024-02-16 06:12:23 -0600 | Rating Details | |
| 2024-02-16 06:11:49 -0600 | Rating Details | |
| 2024-02-16 06:09:59 -0600 | Rating Details | |
| 2024-02-16 05:48:50 -0600 | Rating Details | |
| 2024-02-17 06:19:34 -0600 | Rating Details | |
| 2024-02-17 00:50:34 -0600 | Rating Details | |
| 2024-02-17 00:31:37 -0600 | Rating Details | |
| 2024-02-16 23:33:11 -0600 | Rating Details | |
| 2024-02-16 21:02:30 -0600 | Rating Details | |
| 2024-02-16 19:50:03 -0600 | Rating Details | |
| 2024-02-16 17:16:25 -0600 | Rating Details | |
| 2024-02-16 16:56:26 -0600 | Rating Details | |
| 2024-02-16 12:53:50 -0600 | Rating Details | |
| 2024-02-16 11:37:28 -0600 | Rating Details | |
| 2024-02-16 10:41:10 -0600 | Rating Details | |
| 2024-02-16 10:20:15 -0600 | Rating Details | |
| 2024-02-16 07:35:20 -0600 | Rating Details | |
| 2024-02-16 07:34:07 -0600 | Rating Details | |
| 2024-02-16 07:29:08 -0600 | Rating Details | |
| 2024-02-16 07:12:27 -0600 | Rating Details | |
| 2024-02-16 06:53:59 -0600 | Rating Details | |
| 2024-02-16 06:49:46 -0600 | Rating Details | |
| 2024-02-16 06:42:27 -0600 | Rating Details | |
| 2024-02-16 06:41:13 -0600 | Rating Details | |
| 2024-02-16 06:27:08 -0600 | Rating Details | |
| 2024-02-16 06:23:17 -0600 | Rating Details | |
| 2024-02-16 06:18:33 -0600 | Rating Details | |
| 2024-02-16 06:06:27 -0600 | Rating Details | |
| 2024-02-16 06:02:34 -0600 | Rating Details | |
| 2024-02-16 06:02:07 -0600 | Rating Details | |
| 2024-02-16 05:59:14 -0600 | Rating Details | |
| 2024-02-16 05:49:07 -0600 | Rating Details | |
| 2024-02-22 18:51:23 -0600 | Rating Details | |
| 2024-03-03 03:30:27 -0600 | Rating Details | |
| 2024-02-22 06:17:37 -0600 | Rating Details | |
| 2024-02-19 07:56:27 -0600 | Rating Details | |
| 2024-02-17 10:05:15 -0600 | Rating Details | |
| 2024-02-17 02:52:11 -0600 | Rating Details | |
| 2024-02-17 01:44:53 -0600 | Rating Details | |
| 2024-02-16 22:47:25 -0600 | Rating Details | |
| 2024-02-16 20:26:57 -0600 | Rating Details | |
| 2024-02-16 18:29:16 -0600 | Rating Details | |
| 2024-02-16 15:49:38 -0600 | Rating Details | |
| 2024-02-16 13:48:54 -0600 | Rating Details | |
| 2024-02-16 10:16:06 -0600 | Rating Details | |
| 2024-02-16 08:33:46 -0600 | Rating Details | |
| 2024-02-16 08:32:05 -0600 | Rating Details | |
| 2024-02-16 08:19:55 -0600 | Rating Details | |
| 2024-02-16 08:07:34 -0600 | Rating Details | |
| 2024-02-16 07:34:21 -0600 | Rating Details | |
| 2024-02-16 07:01:25 -0600 | Rating Details | |
| 2024-02-16 06:54:37 -0600 | Rating Details | |
| 2024-02-16 06:54:11 -0600 | Rating Details | |
| 2024-02-16 06:50:30 -0600 | Rating Details | |
| 2024-02-16 06:37:12 -0600 | Rating Details | |
| 2024-02-16 06:32:41 -0600 | Rating Details | |
| 2024-02-16 06:25:05 -0600 | Rating Details | |
| 2024-02-16 06:24:08 -0600 | Rating Details | |
| 2024-02-16 06:14:08 -0600 | Rating Details | |
| 2024-02-16 06:05:21 -0600 | Rating Details | |
| 2024-02-16 06:05:18 -0600 | Rating Details | |
| 2024-02-16 06:02:50 -0600 | Rating Details | |
| 2024-02-16 05:57:40 -0600 | Rating Details | |
| 2024-02-19 18:13:49 -0600 | Rating Details | |
| 2024-09-19 12:44:15 -0500 | Rating Details | |
| 2024-09-18 14:55:27 -0500 | Rating Details | |
| 2024-09-18 03:34:09 -0500 | Rating Details | |
| 2024-09-18 03:15:20 -0500 | Rating Details | |
| 2024-09-17 22:27:03 -0500 | Rating Details | |
| 2024-09-17 22:17:03 -0500 | Rating Details | |
| 2024-09-17 18:04:10 -0500 | Rating Details | |
| 2024-09-17 16:21:21 -0500 | Rating Details |